1800-272-662
Shopping Cart 0
countryflagAU
Login

Enovis Corp

Industrials US ENOV

23.89USD
-0.77(3.12%)

Last update at 2026-03-10T20:00:00Z

Day Range

23.5824.90
LowHigh

52 Week Range

43.0466.71
LowHigh

Fundamentals

  • Previous Close 24.66
  • Market Cap2950.81M
  • Volume975170
  • P/E Ratio-
  • Dividend Yield19.55%
  • EBITDA200.01M
  • Revenue TTM1660.89M
  • Revenue Per Share TTM30.54
  • Gross Profit TTM 883.88M
  • Diluted EPS TTM-2.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -2.06900M 165.39M 58.03M 50.49M 182.80M
Minority interest -1.53300M -4.62100M -3.14600M -10.50000M -14.27700M
Net income -38.18900M 98.69M 64.08M 18.86M 140.20M
Selling general administrative 772.91M 1329.38M 1087.40M 1132.15M 818.21M
Selling and marketing expenses - - - - -
Gross profit 869.38M 1613.66M 1288.11M 1401.06M 1132.84M
Reconciled depreciation 219.71M 262.92M 246.23M 236.03M 141.88M
Ebit -88.57000M 256.64M 162.29M 203.61M 314.67M
Ebitda 131.14M 558.41M 446.93M 471.32M 456.55M
Depreciation and amortization 219.71M 301.77M 284.64M 267.70M 141.88M
Non operating income net other -18.30800M -29.87000M - - -
Operating income -88.57000M 256.64M 162.29M 203.61M 236.94M
Other operating expenses 1653.76M 3570.02M 2870.07M 3058.55M 3352.18M
Interest expense 24.05M 72.59M 104.26M 119.50M 44.05M
Tax provision 36.12M 66.69M -6.05300M 31.63M -0.02100M
Interest income - - - - -
Net interest income -24.05200M -72.59300M -104.26200M -119.50300M -44.05200M
Extraordinary items - - - - -
Non recurring -19.48000M 27.64M - - -
Other items - - - - -
Income tax expense 36.12M 66.69M -6.05300M 31.63M -0.02100M
Total revenue 1563.10M 3854.30M 3070.77M 3327.46M 3666.81M
Total operating expenses 960.04M 1329.38M 1087.40M 1132.15M 818.21M
Cost of revenue 693.72M 2240.64M 1782.66M 1926.40M 2533.97M
Total other income expense net 86.50M -91.25500M -104.26200M -153.11900M -87.77500M
Discontinued operations 26.43M -22.41500M -18.31100M -536.00900M 32.60M
Net income from continuing ops -38.18900M 98.69M 64.08M 18.86M 182.82M
Net income applicable to common shares -13.29200M 71.66M 42.62M -527.64600M 140.20M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 4273.25M 8515.34M 7351.55M 7386.83M 6603.87M
Intangible assets 1110.73M 1675.46M 1663.45M 1719.02M 1012.91M
Earning assets - - - - -
Other current assets 48.16M 90.73M 113.42M 161.19M 227.47M
Total liab 823.45M 3853.91M 3763.68M 3897.20M 3126.93M
Total stockholder equity 3448.09M 4617.38M 3543.39M 3441.43M 3269.76M
Deferred long term liab 4.50M 5.20M 7.00M 6.10M 2.20M
Other current liab 206.73M 479.63M 417.60M 453.88M 405.04M
Common stock 0.05M 0.16M 0.12M 0.12M 0.12M
Capital stock 0.05M 0.16M 0.12M 0.12M 0.12M
Retained earnings 575.73M 589.02M 517.37M 479.56M 991.84M
Other liab 166.99M 606.32M 608.62M 619.31M 747.26M
Good will 1983.59M 3467.30M 3314.54M 3202.52M 2576.62M
Other assets 63.79M 363.49M 350.83M 396.49M 2204.23M
Cash 24.30M 719.37M 97.07M 109.63M 245.02M
Cash and equivalents - - - - -
Total current liabilities 565.20M 1023.58M 811.66M 857.31M 1199.35M
Current deferred revenue 3.56M 31.47M 36.74M 16.01M 147.31M
Net debt 286.24M 1512.95M 2273.41M 2338.59M 953.72M
Short term debt 219.28M 8.31M 27.07M 27.64M 6.33M
Short long term debt 219.28M 8.31M 27.07M 27.64M 6.33M
Short long term debt total 310.54M 2232.32M 2370.47M 2448.22M 1198.74M
Other stockholder equity 2925.73M 4544.21M 3478.01M 3445.60M 3057.98M
Property plant equipment 236.74M 705.82M 660.90M 664.56M 327.15M
Total current assets 795.02M 2303.28M 1361.83M 1404.24M 1958.44M
Long term investments - - - - -
Net tangible assets 353.77M -525.37900M -1434.60000M -1480.10600M 1143.63M
Short term investments - - - - 0.00000M
Net receivables 267.38M 638.70M 517.01M 561.87M 989.42M
Long term debt 40.00M 2078.68M 2204.17M 2284.18M 1192.41M
Inventory 426.64M 776.29M 564.82M 571.56M 496.54M
Accounts payable 135.63M 504.17M 330.25M 359.78M 640.67M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 1.72M 44.05M - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -53.43000M -516.01300M -452.10600M -483.84500M -780.17700M
Additional paid in capital - - - - -
Common stock total equity 0.05M 0.16M - - -
Preferred stock total equity - - - - -
Retained earnings total equity 575.73M 589.02M - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 80.29M 363.49M 350.83M 396.49M 552.56M
Deferred long term asset charges - - - - -
Non current assets total 3478.22M 6212.07M 5989.72M 5982.59M 4645.43M
Capital lease obligations 51.26M 187.73M 178.93M 176.42M -
Long term debt total 40.00M 2078.68M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -176.38800M -320.47600M -175.07900M -1632.75700M 139.48M
Change to liabilities -11.84300M 178.47M -30.74700M -119.32500M 70.08M
Total cashflows from investing activities -176.38800M -320.47600M -175.07900M -1632.75700M -167.85100M
Net borrowings -1606.80300M -126.03200M -118.31600M 1108.78M 158.24M
Total cash from financing activities -465.12700M 584.91M -131.65100M 1369.49M -47.15300M
Change to operating activities -46.46400M 45.38M -30.73400M -17.16900M 16.14M
Net income -11.75900M 76.28M 45.77M -517.14600M 154.47M
Change in cash -695.07500M 618.30M -8.56300M -135.38700M -17.00000M
Begin period cash flow 719.37M 101.07M 109.63M 245.02M 262.02M
End period cash flow 24.30M 719.37M 101.07M 109.63M 245.02M
Total cash from operating activities -55.86100M 356.10M 301.94M 130.95M 226.37M
Issuance of capital stock 5.81M 745.18M 3.50M 11.88M 4.70M
Depreciation 219.71M 262.92M 246.23M 236.03M 141.88M
Other cashflows from investing activities -70.93800M -216.23900M - - -
Dividends paid - - - - 1271.05M
Change to inventory -118.79100M -129.96700M 23.79M -44.88700M -47.15600M
Change to account receivables -45.18900M -110.98500M 42.69M 49.92M -72.40500M
Sale purchase of stock 5.81M 745.18M 0.00000M 0.00000M -200.00000M
Other cashflows from financing activities 1120.22M 957.25M 843.85M 5018.92M 2532.01M
Change to netincome 61.14M 41.42M 13.69M 558.73M -22.37400M
Capital expenditures 105.45M 104.24M 114.78M 125.40M 69.65M
Change receivables -45.18900M -110.98500M - - -
Cash flows other operating -149.13300M 34.18M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -697.37600M 620.53M - - -
Change in working capital -220.49400M -17.10100M 4.99M -131.45700M -33.33200M
Stock based compensation 38.95M 35.35M 28.91M 21.96M 25.10M
Other non cash items -88.59300M 20.84M 5.25M 522.15M 4.82M
Free cash flow -161.31100M 251.86M 187.15M 5.55M 156.72M

Peer Comparison

Sector: Industrials Industry: Specialty Industrial Machinery

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ENOV
Enovis Corp		 -0.77 3.12% 23.89 - 20.41 1.78 0.86 2.04 21.55
SIEGY
Siemens AG ADR		 3.48 2.67% 133.93 17.07 15.75 1.88 2.76 2.37 11.38
SMAWF
Siemens AG Class N		 -1.68 0.62% 268.82 16.98 15.53 1.83 2.72 2.35 11.32
GE
GE Aerospace		 4.59 1.43% 326.52 12.87 26.60 1.61 4.69 1.61 8.43
SBGSY
Schneider Electric SA		 0.66 1.14% 58.79 25.90 20.92 3.12 3.98 3.50 17.37

Reports Covered

Stock Research & News

View All

Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Enovis Corp

2711 Centerville Road, Wilmington, DE, United States, 19808

Key Executives

Name Title Year Born
Mr. Mitchell P. Rales Co-Founder & Independent Chairman 1957
Mr. Matthew L. Trerotola CEO & Director 1967
Mr. Brady R. Shirley Pres, COO & Director 1966
Mr. Christopher M. Hix Exec. VP of Fin. & CFO 1962
Mr. Daniel A. Pryor Exec. VP of Strategy & Bus. Devel. 1968
Mr. John Kleckner Principal Accounting Officer 1977
Mr. Michael S. Macek VP of Fin. & Investor Relations 1972
Mr. Bradley J. Tandy Sr. VP & Gen. Counsel 1959
Katie Sweet VP of Corp. Communication NA
Ms. Patricia A. Lang Sr. VP & Chief HR Officer 1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.